Discover 2,380 paid clinical trials in Plainfield, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Plainfield offers many clinical trial opportunities with focuses on various conditions, including ADHD, prurigo nodularis, autoimmune diseases like lupus, and cardiovascular conditions. The city's leading institutions are actively recruiting both healthy volunteers interested in paid research options, as well as those with specific health conditions for studies that could lead to groundbreaking discoveries and improved treatments.
Filter
2
Filter results
Results: 2,380
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
for
Breast Cancer, HER2-low Breast Cancer, Metastatic Breast Cancer,
Location: Chicago IL, Nashville TN, Birmingham AL,
Sponsor: Ana C Garrido-Castro, MD
Sex: All
Age: 18+
Code: NCT06533826
Phase 2, Recruiting
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
for
Metastatic Breast Cancer
Location: Chicago IL, Birmingham AL, Chapel Hill NC,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT06099769
Phase 2, Recruiting
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
for
Ischemic Stroke, Intracerebral Hemorrhage,
Location: Chicago IL, Indianapolis IN, Cincinnati OH,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT04916210
Recruiting
Aspirin and Preeclampsia
for
Preeclampsia Postpartum
Location: Chicago IL
Sponsor: University of Chicago
Sex: Female
Age: 18 - 45
Code: NCT04479072
Recruiting
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
for
Solid Tumor
Location: Chicago IL, Iowa City IA, St Louis MO, Detroit MI,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT04939610
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
for
Wilms Tumor, Rhabdoid Tumor,
Location: Chicago IL, St Louis MO, Cincinnati OH, Atlanta GA,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 1+
Code: NCT05985161
Phase 2, Recruiting
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
for
Relapsed/Refractory Multiple Myeloma
Location: Chicago IL, Milwaukee WI, Atlanta GA, Chapel Hill NC,
Sponsor: Ichnos Sciences SA
Sex: All
Age: 18+
Code: NCT05862012
Phase 1, Recruiting
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
for
Systemic Lupus Erythematosus, Lupus Nephritis
Location: Chicago IL, Minneapolis MN, Kansas City KS,
Sponsor: Cabaletta Bio
Sex: All
Age: 12 - 65
Code: NCT06121297
Phase 1, Phase 2, Recruiting
Islet Transplantation in Patients With "Brittle" Type I Diabetes
for
Diabetes Mellitus, Type 1
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18 - 70
Code: NCT01630850
Recruiting
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
for
Ovarian Cancer
Location: Chicago IL
Sponsor: Canadian Cancer Trials Group
Sex: Female
Age: 18+
Code: NCT04918186
Phase 2, Recruiting
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Chicago IL, Detroit MI, Columbus OH, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT04590326
Phase 1, Phase 2, Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for
Melanoma, Cutaneous Malignant, Mucosal Melanoma
Location: Chicago IL, Madison WI, Ann Arbor MI, Rochester MN,
Sponsor: Immatics US, Inc.
Sex: All
Age: 18+
Code: NCT06743126
Phase 3, Recruiting
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)